| Michael Ernest Bennett, MD | |
|
938 Bannock St, Ste. 300, Denver, CO 80204-4028 | |
| (303) 914-8800 | |
| Not Available |
| Full Name | Michael Ernest Bennett |
|---|---|
| Gender | Male |
| Speciality | Radiology - Neuroradiology |
| Location | 938 Bannock St, Denver, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083698385 | NPI | - | NPPES |
| 47053739 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085N0700X | Radiology - Neuroradiology | 200400806 (North Carolina) | Secondary |
| 2085N0700X | Radiology - Neuroradiology | 44660 (Colorado) | Primary |
| Entity Name | Diversified Radiology Of Colorado Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205923596 PECOS PAC ID: 0143132316 Enrollment ID: O20031105000319 |
News Archive
A new drug called FG-2216 can stimulate production of the hormone erythropoietin (EPO) in dialysis patients—possibly offering a new approach to treatment of kidney disease-related anemia, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
In 2017 and 2019, the German Institute for Quality and Efficiency in Health Care had already examined the advantages and disadvantages of ribociclib in combination with an aromatase inhibitor or fulvestrant in comparison with the appropriate comparator therapy in patients after menopause, with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
A study published in today's British Medical Journal suggests that banning smoking in a community can result in an almost immediate drop-off in the number of heart attacks in that community. The study, which was originally presented at the 52nd Annual College of Cardiology Scientific Session in 2003, examined the number of people in Helena, Mont., who were admitted to the hospital for a heart attack before, during and after a local ordinance banned smoking in public and workplaces.
Traumatized people who take a class of common blood pressure medications tend to have less severe post-traumatic stress symptoms, researchers have found.
› Verified 5 days ago
| Entity Name | Colorado Permanente Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760599724 PECOS PAC ID: 1254238454 Enrollment ID: O20031216000640 |
News Archive
A new drug called FG-2216 can stimulate production of the hormone erythropoietin (EPO) in dialysis patients—possibly offering a new approach to treatment of kidney disease-related anemia, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
In 2017 and 2019, the German Institute for Quality and Efficiency in Health Care had already examined the advantages and disadvantages of ribociclib in combination with an aromatase inhibitor or fulvestrant in comparison with the appropriate comparator therapy in patients after menopause, with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
A study published in today's British Medical Journal suggests that banning smoking in a community can result in an almost immediate drop-off in the number of heart attacks in that community. The study, which was originally presented at the 52nd Annual College of Cardiology Scientific Session in 2003, examined the number of people in Helena, Mont., who were admitted to the hospital for a heart attack before, during and after a local ordinance banned smoking in public and workplaces.
Traumatized people who take a class of common blood pressure medications tend to have less severe post-traumatic stress symptoms, researchers have found.
› Verified 5 days ago
| Entity Name | Spectrum Medical Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164881652 PECOS PAC ID: 1355647595 Enrollment ID: O20160314001910 |
News Archive
A new drug called FG-2216 can stimulate production of the hormone erythropoietin (EPO) in dialysis patients—possibly offering a new approach to treatment of kidney disease-related anemia, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
In 2017 and 2019, the German Institute for Quality and Efficiency in Health Care had already examined the advantages and disadvantages of ribociclib in combination with an aromatase inhibitor or fulvestrant in comparison with the appropriate comparator therapy in patients after menopause, with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
A study published in today's British Medical Journal suggests that banning smoking in a community can result in an almost immediate drop-off in the number of heart attacks in that community. The study, which was originally presented at the 52nd Annual College of Cardiology Scientific Session in 2003, examined the number of people in Helena, Mont., who were admitted to the hospital for a heart attack before, during and after a local ordinance banned smoking in public and workplaces.
Traumatized people who take a class of common blood pressure medications tend to have less severe post-traumatic stress symptoms, researchers have found.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Ernest Bennett, MD 1746 Cole Blvd, Ste 150, Lakewood, CO 80401-3267 Ph: (303) 914-8800 | Michael Ernest Bennett, MD 938 Bannock St, Ste. 300, Denver, CO 80204-4028 Ph: (303) 914-8800 |
News Archive
A new drug called FG-2216 can stimulate production of the hormone erythropoietin (EPO) in dialysis patients—possibly offering a new approach to treatment of kidney disease-related anemia, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
In 2017 and 2019, the German Institute for Quality and Efficiency in Health Care had already examined the advantages and disadvantages of ribociclib in combination with an aromatase inhibitor or fulvestrant in comparison with the appropriate comparator therapy in patients after menopause, with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
A study published in today's British Medical Journal suggests that banning smoking in a community can result in an almost immediate drop-off in the number of heart attacks in that community. The study, which was originally presented at the 52nd Annual College of Cardiology Scientific Session in 2003, examined the number of people in Helena, Mont., who were admitted to the hospital for a heart attack before, during and after a local ordinance banned smoking in public and workplaces.
Traumatized people who take a class of common blood pressure medications tend to have less severe post-traumatic stress symptoms, researchers have found.
› Verified 5 days ago
Dr. Manuel D Aquino, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 9400 E Iliff Ave Apt 41, Denver, CO 80231 Phone: 720-934-4537 | |
Dr. Robert Ward Burman, M.D., PH.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2045 N Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
Dr. John H Bair, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2045 Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
Gary W. Bauerle, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 938 Bannock St, Ste 300, Denver, CO 80204 Phone: 303-914-8800 Fax: 303-716-3777 | |
Dr. Sara Louise Anschuetz, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2490 W 26th Ave, Suite 220, Denver, CO 80211 Phone: 303-433-9729 Fax: 303-480-0405 | |
Dr. Jeffrey D Wicks, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2490 W 26th Ave, Suite 220, Denver, CO 80211 Phone: 303-433-9729 Fax: 303-480-0405 | |
Christopher Ryan Deig, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1721 E 19th Ave, #520, Denver, CO 80218 Phone: 812-449-1243 |